Global Thin Film Drug Manufacturing Market Size Study, by Product (Oral Thin Film, Sublingual Film, Fully Dissolving Dental/Buccal Film, Transdermal Thin Film, Others), by Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting,

Global Thin Film Drug Manufacturing Market Size Study, by Product (Oral Thin Film, Sublingual Film, Fully Dissolving Dental/Buccal Film, Transdermal Thin Film, Others), by Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-commerce), and Regional Forecasts 2022-2032

The Global Thin Film Drug Manufacturing Market was valued at USD 6.4 billion in 2023 and is projected to grow with a compound annual growth rate (CAGR) of 9.0% from 2024 to 2032. Thin film drug manufacturing involves the design and production of thin films containing biochemical elements for pharmaceutical purposes, which can be administered sublingually, orally, or via transdermal methods. These advanced drug delivery systems offer precise dosage, improved patient compliance, ease of administration, and rapid onset of biological effects, making them especially beneficial for children and the elderly.

The increasing global elderly population, driven by improvements in healthcare facilities and a decline in birth rates, is a prominent contributor to the growth of the thin film drug manufacturing market. Thin film drug delivery systems are particularly advantageous for the elderly, as they reduce the risk of choking, ease swallowing difficulties, and improve the overall administration of drugs. The rise in investment in drug delivery technologies is another significant factor augmenting the market size. The surge in integration of nanotechnology in drug delivery, targeted drug deliveries, and personalized medicine for improved patient care and quality of life are gaining traction. Leading players in the global market are innovating to provide cost-effective and convenient formulations, further driving market growth.

The key regions considered for the Global Thin Film Drug Manufacturing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. North America is the dominating region in the Global Thin Film Drug Manufacturing Market. This dominance is primarily attributed to the region's advanced healthcare infrastructure, significant investment in research and development, and the presence of major pharmaceutical companies. The United States, in particular, leads in innovation and adoption of advanced drug delivery technologies, including thin film drug manufacturing. Additionally, favorable regulatory policies and substantial funding from both government and private sectors support the development and commercialization of thin film drug products. Moreover, Asia Pacific is projected to register fastest growth during to forecast period owing to rising disease prevalence, rising government initiatives for drug manufacturing in the region.

Major market player included in this report are:

Pfizer, Inc.

Novartis AG

Wolters Kluwer

Solvay

AbbVie

Sumitomo Pharma Co., Ltd

IntelGenx Corp.

NAL Pharma

ZIM Laboratories Limited

Indivior PLC

MonoSol

GSK (GlaxoSmithKline plc)

Cure Pharmaceutical Holding Corp.

Sumitomo Dainippon Pharma Co., Ltd.

Allergan plc

The detailed segments and sub-segment of the market are explained below:

By Product

Oral Thin Film

Sublingual Film

Fully Dissolving Dental/Buccal Film

Transdermal Thin Film

Others

By Disease Indication

Schizophrenia

Migraine

Opioid Dependence

Nausea & Vomiting

Others

By Distribution Channel

Hospital Pharmacies

Drug Stores

Retail Pharmacies

E-commerce

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE (Rest of Europe)

Asia Pacific

China

India

Japan

Australia

RoAPAC (Rest of Asia Pacific)

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

RoMEA (Rest of Middle East & Africa)

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.